Natus Medical provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Co. provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for newborn jaundice, software systems for managing and tracking disorders and diseases for public health laboratories, computer-based audiological, otoneurologic and vestibular instrumentation for hearing and balance care personnel. We show 13 historical shares outstanding datapoints in our coverage of NTUS's shares outstanding history.
Understanding the changing numbers of NTUS shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NTUS versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NTUS by allowing them to research NTUS shares outstanding history
as well as any other stock in our coverage universe. |
Free NTUS Email Alerts:
Video: Shares Outstanding Importance
